Abstract
A number of studies during the nineties have shown that antihypertensive therapy, particularly using RAS blockade, can reduce uremia progression, and ESRD incidence.
Originalsprog | Engelsk |
---|---|
Tidsskrift | B M C Nephrology |
Vol/bind | 13 |
Sider (fra-til) | 131 |
ISSN | 1471-2369 |
DOI | |
Status | Udgivet - 2012 |